Hirsch Andrew Insider Trades

Insider Trading History

Track insider trading activity for Hirsch Andrew. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $4.48M 1,074,934 shares
Last Trade
Feb 15, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$17.1k 9,057 shares
$1.89
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $4.52M 1,083,991 shares
Last Trade
Feb 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$38.6k 20,400 shares
$1.89
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $4.52M 1,083,991 shares
Last Trade
Feb 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$74k 39,154 shares
$1.89
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $4.68M 1,123,145 shares
Last Trade
Feb 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$154k 81,725 shares
$1.89
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $4.68M 1,123,145 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.32M 700,000 shares
$1.89
$4.17
Editas Medicine
Editas Medicine EDIT
Director
Holding Value $112k 37,500 shares
Last Trade
Jun 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.6k 37,500 shares
$1.91
$2.99
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $1.76M 423,145 shares
Last Trade
Feb 15, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$29.8k 9,370 shares
$3.18
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $1.86M 445,362 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.07M 335,300 shares
$3.18
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $1.8M 432,515 shares
Last Trade
Feb 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$40.9k 12,847 shares
$3.18
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $948k 227,412 shares
Last Trade
Nov 07, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$75.5k 12,500 shares
$6.04
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $146k 35,000 shares
Last Trade
Nov 07, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$75.5k 12,500 shares
$6.04
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $925k 221,862 shares
Last Trade
Nov 07, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$33.5k 5,550 shares
$6.04
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $896k 214,912 shares
Last Trade
Sep 16, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.2k 3,329 shares
$6.36
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $910k 218,241 shares
Last Trade
Sep 16, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47.7k 7,500 shares
$6.36
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $198k 47,500 shares
Last Trade
Sep 16, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47.7k 7,500 shares
$6.36
$4.17
Editas Medicine
Editas Medicine EDIT
Director
Holding Value $74.8k 25,000 shares
Last Trade
May 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 25,000 shares
$5.17
$2.99
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $879k 210,741 shares
Last Trade
Feb 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$51.8k 6,560 shares
$7.90
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $1.94M 465,500 shares
Last Trade
Feb 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.4M 465,500 shares
$7.31
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $2.04M 489,600 shares
Last Trade
Sep 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.05M 489,600 shares
$2.15
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
President & CEO
Holding Value $484k 116,106 shares
Last Trade
Aug 30, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22k 7,500 shares
$2.93
$4.17

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up